Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis

Hyperprogressive disease (HPD) is a recently acknowledged pattern of rapid tumor progression after the initiation of immune checkpoint inhibitors. HPD has been observed across various types of tumors and has been associated with poor survival. We performed a meta-analysis to identify baseline (i.e.,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Kim, Jong Yeob, Lee, Keum Hwa, Kang, Jeonghyun, Borcoman, Edith, Saada-Bouzid, Esma, Kronbichler, Andreas, Hong, Sung Hwi, de Rezende, Leandro Fórnias Machado, Ogino, Shuji, Keum, Nana, Song, Mingyang, Luchini, Claudio, van der Vliet, Hans J., Shin, Jae Il, Gamerith, Gabriele
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896059/
https://ncbi.nlm.nih.gov/pubmed/31683809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11111699
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars